血清肿瘤标志物均为阴性。
血清肿瘤标志物联合检测可提高诊断肺癌敏感性。
The sensitivity of lung cancer diagnosis is raised by combined assay with serum tumor marker.
目的探索血清肿瘤标志物联合检测在卵巢癌诊断中的应用价值。
Objective To explore value of the serum tumor markers in early stage diagnosis of ovarian cancer.
目的研究血清肿瘤标志物的变化与结直肠癌中医辨证分型的相关性。
Objective To study the correlation between blood serum tumor markers and TCM syndromes of colorectal cancer.
目的：评价血清肿瘤标志物CA15 - 3在乳腺癌中的临床应用价值。
Objective:To evaluate the clinical significance of serum tumor marker CA15-3 in patients with breast cancer.
目的：探讨联检血清肿瘤标志物和放射性核素骨显像对诊断乳腺癌骨转移的临床价值。
Objective: To assess the value of combined testing of serum tumor markers in the diagnosis of gallbladder carcinoma.
完成手术及化疗后无肿瘤迹象6个月以上，又出现盆腔或腹腔包块，或血清肿瘤标志物又上升。
There is no tumor found for 6 months after completed operation and chemotherapy, and then there is a tumor again found in abdomen or the blood markers increasing again.
结论合理利用血清肿瘤标志物检查肺癌患者，既有助于诊断，又可做到合理检查、避免资源浪费。
Utilizing serum tumor markers reasonably to detect lung cancer patients was not only better for diagnose, but also for reasonable detection and avoiding wasting resources.
与多项血清肿瘤标志物检测联合应用，能够进一步改善诊断的敏感性和特异性，提高早期诊断和鉴别诊断水平。
Combined with multiple serum tumor marker measurements, this method can improve diagnostic sensitivity and specificity, he nce it facilitates the early diagnosis and differential diagnosis.
目的观察胰腺肿瘤介入化疗术前后相关血清肿瘤标志物糖链抗原19 9（CA19 9）、糖类抗原2 4 2（CA2 4 2 ）及癌胚抗原（CEA）的水平变化及其意义。
Objective To observe the changes of the levels of serum tumor markers, i. e. CA19-9, CA242 and CEA, and their significance during the interventional chemotherapy for pancreatic carcinoma.
熟悉鞍区畸胎瘤的影像学特点，全面的组织病理学检查、血清及脑脊液肿瘤标志物检测是诊断和治疗的重要依据。
To be familiar with the characteristics of image, comprehensive histopathologic examination combined with serum and CSF tumors markers detection were necessary for correct diagnosis and treatment.
结论采用C - 12系统检测乳管液肿瘤标志物的灵敏度明显高于血清，但特异性较差。
Conclusion By applying the C-12 system determination the tumor maker, the sensitivity of breast duct juice surpasses than in serum, but the specificity is not fine.
结论：胃肠道癌患者血清中抗癌胚抗原(CEA)抗体的检出率较高，这些抗体可作为胃肠道癌的一种肿瘤标志物。
Conduskm: in this study, a high number of gastrointestinal malignancies patients have circulating CEA specific antibodies in their sera and these antibodies may be used as diagnostic markers.
结论：联合检测血清与腹水肿瘤标志物可提高诊断正确率，减少误诊与漏诊。
Conclusion: The combined assay of tumor mark in serum and ascitic fluid can enhance diagnostic accuracy.
目的通过测定血管内皮生长因子(VEGF)在肿瘤患者血清及恶性渗出液中的含量，以明确VEGF能否作为肿瘤标志物。
Objective to determine whether vascular endothelial growth factor (VEGF) could be used as a tumor marker by detecting the VEGF levels in serum and effusion from malignant tumor patients.
结果显示：卵巢癌组与良性肿瘤组和对照组相比，三项标志物的血清含量有显著性差异（P<0．05）。
The results showed that the levels of three tumor markers in ovarian cancer patients were significantly higher than those in benign tumor patients and controls(P<0. 05).
目的：探讨联合测定血清与腹水肿瘤标志物对消化系恶性肿瘤的诊断价值。
Purpose: To evaluate the diagnostic value of the combined assay of tumor mark in serum and ascitic fluid to the alimentary system malignant neoplasm.
目的：探讨胃癌患者血浆脂联素及血清中三种肿瘤标志物cea、CA125、CA199水平的变化及其临床意义。
Objective: To investigate the clinical significance of plasma adiponectin and three kinds of tumor marker, such as CEA, CA125, CA199 levels in patients with gastric cancer.
结论：血清nse是一种有效的肺癌肿瘤标志物。
Conclusion NSE can be used as a useful tumor marker in patients with lung cancer.
目的探讨联合检测血清中肿瘤标志物甲胎蛋白（AFP）、癌胚抗原（CEA）、糖类抗原125（CA125）、CA19-9对消化系恶性肿瘤的诊断价值。
Objective To explore the clinical value of combined detection of alpha fetoprotein(AFP), carcinoembryonic antigen(CEA), CA125 and CA19-9 in the diagnosis of malignant tumors in digestive system.
目的探讨联合检测血清中肿瘤标志物甲胎蛋白（AFP）、癌胚抗原（CEA）、糖类抗原125（CA125）、CA19-9对消化系恶性肿瘤的诊断价值。
Objective To explore the clinical value of combined detection of alpha fetoprotein(AFP), carcinoembryonic antigen(CEA), CA125 and CA19-9 in the diagnosis of malignant tumors in digestive system.
应用推荐